Novo Nordisk (NVO) stock pares losses as the company plans Ozempic pill launch in Q2 2026 after FDA OKs the name for several oral semaglutide doses. Read more here.

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

Welcome to Stationery Week on the Strategist, where we’ve been obsessively researching and testing office supplies — everything from pens, pencils, and paper to task chairs. For more, head to our ...

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find inspiration for its latest direct-to-consumer Ozempic campaign. The new ads hark ...

Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and ...

Dr. Reddy's reportedly plans to sell 12 million injectable semaglutide pens in the first year of launch. M.V. Ramana, CEO of branded markets, said that while they have permission for the generic ...

A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Jan 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what ...

This article was reviewed by Lynn Marie Morski, MD, JD. Ozempic may help improve testosterone levels in people with overweight or obesity by helping them lose weight, but this is still under ...